Curriculum Vitae - Dr. Vincenzo E. Morabito 2014 Il sottoscritto, ai sensi degli artt. 46 e 47 del D.P.R. 445/2000, consapevole delle conseguenze derivanti da dichiarazioni mendaci ai

sensi dell’art. 76 del D.P.R. 445/2000, dichiara:

1

INFORMAZIONI PERSONALI

Nome VINCENZO Emiliano MORABITO

Luogo di nascita Reggio di Calabria, Italia Data di nascita 11.11.1974

ISTRUZIONE E FORMAZIONE

1992 Conseguimento del diploma di maturità scientifica presso il Liceo “Leonardo da Vinci”

di Reggio di Calabria con votazione 46/60

1992 Iscrizione alla Facoltà di Medicina e Chirurgia presso L’Università di Messina.

1997 Iscrizione alla Facoltà di Medicina e Chirurgia, 4° anno in corso, della Sapienza

Università di Roma, Italy

Da Aprile 2005 a Luglio

2007

Internato di tirocinio pratico ai fini della Tesi di Laurea presso la U.O.C. di Chirurgia

Generale e dei Trapianti d’Organo, diretta dal Prof. P.B. Berloco, II Clinica Chirurgica,

Dipartimento “P. Stefanini”, “Umberto I” Policlinico di Roma.

11 Luglio 2006 Laurea in Medicina e Chirurgia presso “La Sapienza” Università di Roma con voto di

104/110 e lode (tesi dal titolo “Fegato artificiale MARS come fattore predittivo

nell’insufficienza epatica acuta”), relatore Prof. P.B. Berloco.

17 Luglio 2006 Iscrizione all’Ordine Provinciale di Roma dei Medici Chirurghi e degli Odontoiatri

Dal 14 Gennaio 2013 Iscrizione al General Medical Council, UK. Ref. No. 7347043

Da Luglio 2007 a Luglio

2013

Corso di Specializzazione in Chirurgia Generale presso la II Scuola de “la Sapienza”

Università di Roma, Direttore Prof.ssa Chiara Montesani.

29 Luglio 2013 Specializzazione in Chirurgia Generale con votazione massima di 70/70 cum lode con

la tesi “Endotoxin Activity Assay e Polymyxin B-Hemoperfusion per la diagnosi e il

trattamento dell’endotossinemia nei trapianti d’organo”.

ESPERIENZA LAVORATIVA

Da Luglio 2007 a Luglio

2013

Corso di Specializzazione in Chirurgia Generale presso la II Scuola de “la Sapienza”

Università di Roma, Direttore Prof.ssa Chiara Montesani.

Da Luglio2007 a Luglio

2013

Divisione di Chirurgia Generale e dei Trapianti d’Organo, diretta dal Prof. P.B.

Berloco, II Clinica Chirurgica, Dipartimento “P. Stefanini”, “Umberto I”. Medico

Specializzando

Da Novembre 2012 a

Maggio 2013

Division of Hepatology, Sheila Sherlock Unit, Royal Free Hospital and Institute of

Liver and Digestive Health, Liver Failure Group, University College London, Prof.

Rajiv Jalan.

Honorary Clinical and Research Fellow.

Da Gennaio ad Aprile, 2010 Divisione di Chirurgia Toracica e Trapianto di polmone, diretta dal Prof. F.C.Coloni,

Azienda Ospedaliera “Umberto I” Policlinico di Roma. Stage chirurgico ai fini di

formazione professionale.

Da Maggio a Luglio, 2010 Divisione di Chirurgia Vascolare B, diretta dal Prof. F. Speziale, II Padiglione,

Dipartimento “P. Stefanini”, “Umberto I” Policlinico di Roma. Stage chirurgico ai fini

di formazione professionale.

Da Marzo a Maggio, 2009 Reparto di Chirurgia Plastica e Ricostruttiva, diretta dal Prof. R. De Vita, Istituti

Curriculum Vitae - Dr. Vincenzo E. Morabito 2014 Il sottoscritto, ai sensi degli artt. 46 e 47 del D.P.R. 445/2000, consapevole delle conseguenze derivanti da dichiarazioni mendaci ai

sensi dell’art. 76 del D.P.R. 445/2000, dichiara:

2

Fisioterapici Ospedalieri (I.F.O.) di Roma. Stage chirurgico ai fini di formazione

professionale.

Settembre, 2009 Dipartimento di Radiologia, diretta dal Prof. R. Passariello, sotto la tutela del Prof. C.

Catalano, “Umberto I” Policlinico di Roma. Stage ai fini di formazione professionale.

Novembre, 2009 Servizio di Anestesiologia, diretto dal Prof. P. Pietropaoli , sotto la tutela dei Dott. F.

Pugliese e F. Ruberto, II Clinica Chirurgica, Dipartimento “P. Stefanini”, “Umberto I”

Policlinico di Roma. Stage ai fini di formazione professionale.

Ottobre, 2009 Sevizio di Endoscopia Digestiva, diretto dal Prof. G. Mennini, sotto la tutela dei Dott.

P. Trentino e B. Porowska, II padiglione, “Umberto I” Policlinico di Roma. Stage ai

fini di formazione professionale.

Dicembre, 2006 Unità di gastroenterologia, Dipartimento di Scienze Cliniche, “Umberto I” Policlinico

di Roma. Responsabile: Prof. A. Attili. Tirocinio per iscrizione all’ordine dei medici di

Roma.

Gennaio, 2007 Divisione di Chirurgia Generale e dei Trapianti d’Organo, II Clinica Chirurgica,

Dipartimento “P. Stefanini”, “Umberto I” Policlinico di Roma. Responsabile: Prof. P.B.

Berloco. Tirocinio per iscrizione all’ordine dei medici di Roma.

COMPETENZE PERSONALI: LINGUE CONOSCIUTE Lingua Madre Italiano

Altra Lingua

Capacità di lettura

Capacità di scrittura

Capacità verbale

Inglese

Ottimo

Ottimo

Ottimo

Altra Lingua

Capacità di lettura

Capacità di scrittura

Capacità verbale

Francese

Ottimo

Ottimo

Ottimo

COMPETENZE PERSONALI E TECNICHE

2006 Certificazione Corso Matlab, Office Microsoft and Mac OSX.

Uso del programma Prism GraphPad per analisi statistica

Dal 2009 Referee per la seguenti riviste scientifiche:

Therapeutic Apheresis and Dialysis Journal

Artificial Organs Journal

Liver International Journal

Dal 2006 1. Tutorato chirurgico e gestione clinica del reparto di degenza. Prelievo di

organi da donatore cadavere e da donatore vivente, gestione peri e post-

operatoria di pazienti sottoposti a trapianto d’organo (fegato, rene, pancreas)

e ad interventi di chirurgia epato-bilio-pancreatica e colorettale.

2. Valutazione dei donatori e riceventi in lista di attesa per l’allocazione dei reni

per il trapianto d’organo da donatore cadavere.

3. Management delle insufficienze d’organo (fegato e rene), della sepsi e del

trattamento delle infezione da Virus C tramite applicazioni di metodiche

extracorporee:

a)Fegato artificiale e bioartificiale (MARS ed ELAD);

Curriculum Vitae - Dr. Vincenzo E. Morabito 2014 Il sottoscritto, ai sensi degli artt. 46 e 47 del D.P.R. 445/2000, consapevole delle conseguenze derivanti da dichiarazioni mendaci ai

sensi dell’art. 76 del D.P.R. 445/2000, dichiara:

3

b)Polimyxyn B Hemoperfusion per il trattamento dell’attività endotossinica e sepsi

Utilizzo del Test Endotoxin Activity Assay per valutazione attività endotossinica

c)Pathfast Test per valutazione del CD14 solubile come marker precoce dell’infezione

batterica.

d) Trattamenti emodialitici in continuo ed intermittenti

e) Adacolumn Leucocitaferesi per il trattamento Virus C

Dal 2007 al 2013 Guardie Mediche al Dipartimento Paride Stefanini, Umberto I, Policlinico di Roma

2011 Co-Organizatore con il Prof. Gilnardo Novelli del “Workshop sulle Devices

Extracorporee”, 5 Febbbraio 2011, Aula Paride Stefanini, Policlinico “Umberto I”

Roma

2010-2011

2013

Insegnamento al Corso di Laurea Infermieristico, 2° anno, I semestre, IRRSC

Sapienza Università di Roma, per il seguente seminario: “ Detossificazione

Extracorporee e Organi Artificiali”

Insegnamento al Corso di Laurea Specialistica di Ingegneria Biomedica, 1°anno, I

semestre, Facoltà di Ingegneria, Sapienza Università di Roma, per il seguente

seminario : “ Fegato Artificiale MARS e Polymyxin B-Hemoperfusion”.

2013

2013

Progetto di ricerca della Sapienza Università di Roma (prot. C26A12EA2W):

Evaluation of Steatosis: Computer-Assisted Image Analysis and MR Imaging

Risultato Idoneo (posizione n.3° della graduatoria) per reclutamento di n.1 Dirigente

medico- disciplina Chirurgia Generale, per le esigenze del centro Interregionale

Trapianti dell’Organizzazione Centro sud Trapianti per l’attivazione di un contratto a

lavoro determinato.

ATTIVITÀ SCIENTIFICA

Citazioni dal 2006 : 207; H-index : 10; i10-index : 10. Fonti scientifiche: ISI Web and Google Scholar

Publicazioni non indexate

2006 Novelli G, Poli L, Iappelli M, Rossi M, Morabito V, Martelli S, Mennini G, Novelli

L, Corradini S, Berloco PB. Role of Molecular Adsorbent Recirculating system in

treatment of intractable pruritus. Abstract of ASAIO 52nd Annual Meeting, 7-9 June

2006, Chicago,IL,US. ASAIO Journal. March-April 2006 Vol.52 N. 2

2006 Novelli G, Merli M, Rossi M, Iappelli M, Ruberto F, Novelli L, Morabito V, Di folco

G,Nudo F, Berloco PB, MARS treatment in AoCHF patients on Tx waiting list

improves MELD Score.

Abstract of ASAIO 52nd Annual Meeting, 7-9 June 2006, Chicago,IL,US. ASAIO

Journal. March-April 2006 Vol.52 N. 2

2006 Novelli G, Rossi M, Pretagostini R, Morabito V, Mennini G, Berloco P. MARS

treatments as predictive criteria for liver transplantation in liver failure. Abstract of

43rd ERA-EDTA Congress, 15-18 July, Glasgow, Scotland. Nephrology Dialysis

transplantation, Vol.21,S4, 5425, July 2006

2007 G.Novelli, M. Rossi, L. Poli, F. Pugliese, V. Morabito, A. Bussotti, Q. Lai and P.B.

Berloco. Pediatric acute liver failure in treatment with Mars: experience of University

La Sapienza. Abstracts of the XXXIV Annual ESAO (European Society for Artificial

Organs) Congress, Krems, Austria, 3-5 September 2007. International Journal of

Artificial Organs 2007 Aug;30(8):689-748

Curriculum Vitae - Dr. Vincenzo E. Morabito 2014 Il sottoscritto, ai sensi degli artt. 46 e 47 del D.P.R. 445/2000, consapevole delle conseguenze derivanti da dichiarazioni mendaci ai

sensi dell’art. 76 del D.P.R. 445/2000, dichiara:

4

2007 G.Novelli, V.Morabito, M.Rossi, F.Antonellis, Pretagostini R., G.Spoletini, P.Beloco.

MARS treatment in patients with hepatorenal syndrome in acute liver failure. Abstract

of the 27th Annual Conference on Peritoneal Dialysis, 13th International Symposium

on Hemodialysis, and 18th Annual Symposium on Pediatric Dialysis Denver,

Colorado February 18–20, 2007, Hemodialysis International, Vol.11, N.1, 2007

2007 G.Novelli, M.Rossi, R.Pretagostini, L.Poli, F.Nudo, V.Morabito, P.Berloco. MARS

treatment as predictive criteria for liver transplantation in liver failure. Abstract of the

27th Annual Conference on Peritoneal Dialysis, 13th International Symposium on

Hemodialysis, and 18th Annual Symposium on Pediatric Dialysis Denver, Colorado

February 18–20, 2007, Hemodialysis International, Vol.11, N.1, 2007

2007 G.Novelli, V.Morabito, M.Rossi, F.Antonellis, Pretagostini R., G.Spoletini, P.Beloco.

MARS in acute liver failure patients with hepatorenal syndrome. Abstract of ASAIO

53rd Annual Meeting, 7-9 June 2007, Chicago,IL,US. ASAIO Journal. March-April

2007 Vol.53 N. 2

2007 G.Novelli, V.Morabito, M.Rossi, L.Poli, Pretagostini R, P.Beloco. Safety of MARS:

personal experience. Abstract of ASAIO 53rd Annual Meeting, 7-9 June 2007,

Chicago,IL,US. ASAIO Journal. March-April 2007 Vol.53 N. 2

2007 Novelli, G; Rossi, M; Poli, L Morabito V; Pugliese, F; Perrella, SM, Berloco, PB

Pediatric acute liver failure in treatment with MARS. Abstract of 37th Critical Care

Congress of the Society-of-Critical-Care-Medicine FEB 02-08, 2008, Honolulu, HI.

Critical Care Medicine Volume: 35 Issue: 12 Supplement: S Pages: A37-A37,

DEC 2007

2007 Novelli, G; Rossi, M ; Poli, L; Morabito V, Berloco, PB Pugliese, Ruberto,F. Acute

Liver Failure: Hemodynamic parameters improvement through molecular adsorbent

recycling system. Abstract of 37th Critical Care Congress of the Society-of-Critical-

Care-Medicine FEB 02-08, 2008, Honolulu, HI. Critical Care Medicine Volume: 35

Issue: 12 Supplement: S Pages: A38-A38, DEC 2007

2007 Novelli,G Poli, L; Morabito,V; Ruberto, F ; Mennini, G, Bussotti, A , Antonellis, F ,

Rossi, M; Berloco, PB. Mars treatment in HBV patients improves meld score and

follow-up at three months Abstracts of the XXXIV Annual ESAO (European Society

for Artificial Organs) Congress, Krems, Austria, 3-5 September 2007. International

Journal of Artificial Organs 2007 Aug;30(8):689-748.

2008 Novelli G; Rossi M; Morabito V; Pugliese F; Novelli S; Berloco PB Molecular

Adsorbent Recirculating System Versus Standard Medical Therapy. Effects On

Cytokines Levels. International Journal Of Artificial Organs Volume: 31 Issue: 7

Pages: 659-659 Published: JUL 2008

2008 Novelli G; Rossi M; Poli L; Morabito V ; Pugliese F; Ruberto F ; Berloco PB.

Molecular Adsorbent Recycling System: Monitoring Hemodynamic Parameters In

Pantients With Primary No Function. International Journal Of Artificial Organs

Volume: 31 Issue: 7 Pages: 661-661 Published: JUL 2008

2008 Novelli G; Rossi M; Morabito V; Pugliese F; Bussotti A; Berloco, PB. Acute Liver

Failure: Molecular Adsorbent Recycling System As Predictive Criteria Of Survival?

International Journal Of Artificial Organs Volume: 31 Issue: 7 Pages: 661-661

Published: JUL 2008

2008 Novelli G; Rossi, M; Poli L; Morabito V; Nudo F; Pugliese F ; Ruberto, F; Novelli,

S; Berloco, PB Primary Non Function:Timing Re-Transplant Versus Hemodynamic

Parameters And Kidney Function. Abstract of Joint International Congress of the Ilts,

Elita, And Licage Location: Paris, France Date: JUL 09-12, 2008. Liver

Curriculum Vitae - Dr. Vincenzo E. Morabito 2014 Il sottoscritto, ai sensi degli artt. 46 e 47 del D.P.R. 445/2000, consapevole delle conseguenze derivanti da dichiarazioni mendaci ai

sensi dell’art. 76 del D.P.R. 445/2000, dichiara:

5

Transplantation Volume: 14 Issue: 7 Supplement: 1 Pages: S69-S69 Published:

JUL 2008

2009 Lai Q, Nudo F, Levi Sandri GB, Morabito V, Della Pietra F, Catalano C, Bianco P,

Rossi M, Berloco PB. Strategie chirurgiche per l’emangioendotelioma epitelioide

epatico: resezione o trapianto? Acts of the XXXII Congresso Nazionale della Società

Italiana di Chirurgia Oncologica (SICO). Supplement of “Il Giornale di Chirurgia”,

30 (5), 157-160 (2009).

2009 Annesini MC; Morabito V, Novelli G ; Piemonte, V; Turchetti L. Molecular

Adsorbent Recirculating System (MARS): a Chemical Engineering Analysis of In

Vivo Experimental Data. Icheap-9: 9th International Conference On Chemical And

Process Engineering, PTS 1-3 May, 10 - 13, 2009, Rome, Italy. Chemical Engineering

Transactions Volume: 17 Pages: 1095-1100. Pub: 2009

2009

Novelli G; Rossi, M; Pugliese, F; Novelli, S; Morabito, V; Berloco, P. Predictive

Criteria For Patients Outcome With Acute Liver Failure: Albumin Dialysis Mars.

Abstract of 15th Annual Congress of the International-Liver-Transplantation-Society

Location: New York, NY JUL 08-11, 2009. Liver Transplantation Volume:

15, Issue: 7, Pages:S103-S103 Pub: JUL 2009

2009 Novelli, G; Rossi, M; Ferretti, G; Pugliese, F; Morabito, V; Berloco, P . Leukocity-

Apheresis Adacolumn Treatment In Kidney Transplant Patients With Hepatitis C

Virus. Preliminary Study. Abstract of 15th Annual Congress of the International-

Liver-Transplantation-Society. New York, NY JUL 08-11, 2009. Liver

Transplantation Volume: 15, Issue: 7, Pages:S185-S185 Pub: JUL 2009

2009 Novelli G; Rossi, M; Morabito, V; Haiberger, R; Novelli, S; Berloco, P . Albumin

Dialysis Mars In Acute Liver Failure: Predictiva Criteria For Outcome. Transplant

International Volume: 22 Pages: 206-206 Published: Aug 2009

2010 Novelli, G; Rossi, M ; Morabito, V; Ferretti, G ; Pugliese, F; Berloco, PB. Predictive

Parameters after MARS Treatment Integrated with MELD Model in Patients with

Acute on Chronic Liver Failure. Abstract of 16th Annual Congress of the

International-Liver-Transplantation-Society, Hong Kong, JUN 16-19, 2010 Liver

Transplantation Volume: 16 Issue: 6 Supplement: 1 Pages: S246-S246

2010 Novelli, G; Morabito, V; Ferretti, G; Ruberto, F; Poli, L; Rossi,M; Berloco, PB .

Early Management of Endotoxemia Using the Endotoxin Activity Assay and

Polymyxin-B Based Hemoperfusion. Abstract of 16th Annual Congress of the

International-Liver-Transplantation-Society, Hong Kong, JUN 16-19, 2010. Liver

Transplantation Volume: 16. Issue: 6 Supplement: 1 Pages: S246-S246 Published:

JUN 2010

2010 V.Morabito; G.Ferretti; Q.Lai; F.Pugliese; S.Novelli; M.Rossi; PB Berloco;

G.Novelli. Predictive criteria for the outcome of patients with Fulminant Hepatitis

after Molecular Adsorbent Recirculating System treatment. Abstract of 20th APASL

Congress, Bejing, 25-28 March, 2010. Hepatology International , Volume 4, Number

1, March 2010

2010 G.Novelli, V.Morabito, G.Ferretti, L.Poli, M.Rossi, PB Berloco. Early management

of endotoxemia using the Endotoxin Activity Assay and Polymyxin-B based

hemoperfusion. Abstract of 20th APASL Congress, Bejing, 25-28 March, 2010.

Hepatology International , Volume 4, Number 1, March 2010

2010 G.Novelli,V.Morabito,G.Ferretti,L.Poli,F.Ruberto,M.Rossi,PB.Berloco. Endotoxemia

activity in post surgical patients. Role of Endotoxin Activity Assay and Polimyxyn-B

in early management . Abstract of XXXVII Annual Congress of ESAO, Skopje,

Curriculum Vitae - Dr. Vincenzo E. Morabito 2014 Il sottoscritto, ai sensi degli artt. 46 e 47 del D.P.R. 445/2000, consapevole delle conseguenze derivanti da dichiarazioni mendaci ai

sensi dell’art. 76 del D.P.R. 445/2000, dichiara:

6

Macedonia, 8-11 september 2010. International Journal Of Artificial Organs Volume:

33 Issue: 7 Special Issue: SI Pages: 428-429 Published: JUL 2010

2010 Novelli, G; Morabito, V; Novelli, S; Pugliese,; Ferretti, G; Annessini, MC; Rossi, M;

Berloco, PB. Mathematical Model Application For Predictive Criteria In Fulminant

Hepatitis . Abstract of XXXVI Annual Congress of ESAO, Skopje, Macedonia, 8-11

september 2010. International Journal Of Artificial Organs Volume: 33 Issue: 7

Special Issue: SI Pages: 435-435 Published: JUL 2010

2010 Marinozzi F; Novelli S; Morabito V; Rossi, M. Histomorphometric Analysis In The

Progression Of Hepatic Steatosis. Abstract of XXXVII Annual Congress of ESAO,

Skopje, Macedonia, 8-11 september 2010. International Journal Of Artificial Organs

Volume: 33 Issue: 7 Special Issue: SI Pages: 622-622 Published: JUL 2010

2010 V. Morabito, G.Ferretti, F.Ruberto, S.Novelli, PB. Berloco. Endotoxin Activity

Assay for early diagnosis of SIRS in AoCLF patients. Abstract of Monothematic

Conference: Evaluation of Disease Severity and Prognosis in Chronic Liver Disease.

(EASL). 21-23 January 2011, Nice, France. Journal of Hepatology, Vol. 53, N.6, Dec

2010

2010 F.Marinozzi; S.Novelli; V.Morabito; E.Gaudio; P.Bianco; M.Rossi; P.B.Berloco;

G.Novelli. Preliminary study of sinusoids area in the progression of liver disease.

Abstract of Monothematic Conference: Evaluation of Disease Severity and Prognosis

in Chronic Liver Disease. (EASL). 21-23 January 2011, Nice, France. Journal of

Hepatology, Vol. 53, N.6, Dec 2010

2011 Novelli G; Morabito V; Novelli S; Pugliese F; Rossi M; Berloco PB. Mathematical

Model’s Analysis To Improve Albumin Dialysis MARS Treatment. Abstract of 57th

Annual Conference ASAIO, 10-12 June,2011, Washington, US. ASAIO Journal ,

Vol.57,N.2, March-April, 2011

2011 F.Marinozzi; S.Novelli; V.Morabito; E.Gaudio; P.Bianco; M.Rossi; P.B.Berloco;

G.Novelli. Modifications of sinusoids area in the progression of liver disease.

Abstract of 57th Annual Conference ASAIO, 10-12 June,2011, Washington, US.

ASAIO Journal , Vol.57,N.2, March-April, 2011

2011 Morabito V, Ferretti G, Novelli S, Rossi M, Berloco PB. Test EAA for endotoxin

activity in Acute on Chronic Liver Failure. Abstract of XXXVII Annual Congress of

ESAO, Porto,Portogallo, 8-11 October 2011. International Journal Of Artificial

Organs Volume: 34 Issue: 8 Special Issue: SI Pages: 622-622 Published: AUG

2011

2011 G. Novelli; V.Morabito; F.Pugliese; S.Novelli; M.Rossi. Delayed Graft Function in

liver transplant. Role of Molecular Adsorbent Recirculating System. Abstract of

XXXVII Annual Congress of ESAO, Porto,Portogallo, 8-11 October 2011.

International Journal Of Artificial Organs Volume: 34 Issue: 8 Special Issue: SI

Pages: 622-622 Published: Aug 2011

2011 F.Marinozzi ; S.Novelli ; V.Morabito; M.Rossi. Histomorphometric analysis in the

progression of hepatic steatosis. Abstract of XXXVII Annual Congress of ESAO,

Porto, Portogallo, 8-11 October 2011. International Journal Of Artificial Organs

Volume: 34 Issue: 8 Special Issue: SI Pages: 622-622 Published: Aug2011

2011 Novelli, G; Morabito, V; Ferretti, G Ruberto, F; Rossi, M; Berloco, PB. Experience In

Sepsis Patients After Liver Transplants. Abstract of 62nd Annual Meeting of the

American-Association-for-the-Study-of-Liver-Diseases (AASLD) Location: San

Francisco, CA Date: NOV 04-08, 2011 Hepatology Volume: 54 Supplement: 1

Pages: 656A-657A

Curriculum Vitae - Dr. Vincenzo E. Morabito 2014 Il sottoscritto, ai sensi degli artt. 46 e 47 del D.P.R. 445/2000, consapevole delle conseguenze derivanti da dichiarazioni mendaci ai

sensi dell’art. 76 del D.P.R. 445/2000, dichiara:

7

2012 Morabito V. Novelli S. Novelli G. Artificial Liver : What do we need to know about

albumin dialysis MARS? Abstract of 22nd Annual congress of APASL, 16-19

February 2012, Taipei, Taiwan. Hepatology International , Volume 6, Number 1,Jan

2012

2012 V.Morabito, S.Novelli, F.Pugliese, M.Rossi, G.Novelli. Predictive criteria to assess

initial poor graft function in liver transplant . Abstract of 22nd Annual congress of

APASL, 16-19 February 2012, Taipei, Taiwan. Hepatology International , Volume 6,

Number 1,Jan 2012

2012 Morabito V, Ferretti G, Pugliese F, Rossi M, Berloco PB, Novelli G. Preliminary

study for new therapy of Virus C infection in liver transplant. Abstract of 22nd

Annual congress of APASL, 16-19 February 2012, Taipei, Taiwan. Hepatology

International , Volume 6, Number 1,Jan 2012

2012 Morabito, V; Rossi, M; Ferretti, G; Novelli, S; Ruberto; Novelli, G. Early

management of recurrence of Virus C infection in liver transplant. Abstract of 47th

Annual Meeting of EASL, 18-22 april, Barcelona Spain. Journal of

Hepatology.Volume: 56 Supplement: 2 Pages: S90-S90 Meeting Abstract: 213

2012 Morabito, V; Rossi, M; Ferretti, G; Novelli, S ; Ruberto, F; Novelli, G. Endotoxemia

Management In Liver Transplant Patients. Abstract of 47th Annual Meeting of the

European-Association-for-the-Study-of-the-Liver (EASL). Barcelona, Spain. APR 18-

22, 2012. Journal Of Hepatology Volume: 56 Supplement: 2 Pages: S90-S90

Meeting Abstract: 213 . APR 2012

2012 G.Novelli, M.Rossi, V.Morabito, G.Ferretti, F.Pugliese, P.B. Berloco. Change of

immunomodulation of virus C infection in liver transplant patients with an

extracorporeal apheresis. Abstract of International Liver Transplant Society 18th

Annual International Congress, 16-18 May 2012, San Francisco, US. Liver

Transplantation, Volume: 18 Supplement: 1 Pages: S151-S152. MAY 2012

2012 V.Morabito; Lai Q; S.Novelli; F.Pugliese; M.Rossi; G.Novelli. Initial Poor Graft

Failure after liver transplant. Role of albumin dialysis MARS. Abstract of American

Transplant Society, Annual congress, 2-6 June, Boston, US. American Journal of

Transplantation. Volume 12, S3, p256, May 2012

2012 V.Morabito ; G.Ferretti ; F.Ruberto ; M.Rossi; G.Novelli. Endotoxin acitivity

management in liver transplant recipients. Abstract of American Transplant Society,

Annual Congress, 2-6 June, Boston, US. American Journal of Transplantation.

Volume 12, S3, p211, May 2012

2012 Morabito, V ; Ferretti, G; Rossi, M; Novelli, G. Leukocytapheresis treatment for

recurrence Virus C infection in liver transplant recipients. Abstract of 15th ICID

Congress, Bangkok, 13-16 June 2012. International Journal Of Infectious Diseases

Volume: 16 Supplement: 1 Pages: E99-E99, June 2012.

2012 Morabito V; Ferretti, G ; Pugliese, F ; Novelli, S ; Novelli, G. Safety of polymyxin-B-

based hemoperfusion in kidney and liver transplant recipients. Abstract of 15th ICID

Congress, Bangkok, 13-16 June 2012. International Journal Of Infectious Diseases

Volume: 16 Supplement: 1 Pages: E231-E231 Published: JUN 2012

2013 G Novelli, V Morabito, M Rossi, Q Lai, R Pretagostini, F Pugliese, L Poli, S Novelli,

PB Berloco. Predictive Criteria For The Outcome Of Patients With Fulminant

Hepatitis Treated With Mars. Update. Journal of Hepatology 2013, 58, S414

2013 G Novelli, V Morabito, G Ferretti, N Gugliemo, GB Levi Sandri, M Rossi, PB

Berloco. Diagnostic Value Of Presepsin In Cirrhotic Patients. Journal of Hepatology

2013, 58, S95-S96

Curriculum Vitae - Dr. Vincenzo E. Morabito 2014 Il sottoscritto, ai sensi degli artt. 46 e 47 del D.P.R. 445/2000, consapevole delle conseguenze derivanti da dichiarazioni mendaci ai

sensi dell’art. 76 del D.P.R. 445/2000, dichiara:

8

2013 V Morabito, N Gugliemo, GB Levi Sandri, M Rossi, G. Novelli. Dose Adjustment for

Liver Support Based on Kinetic Modelling. Abstract of 23rd Conference of the Asian

Pacific Association for the Study of the Liver. Hepatology International Journal, June

2013, Volume 7, Issue 1 Supplement, pp 1-754

2013 V.Morabito,M.Rossi,L.Poli, S.Novelli, G.Ferretti, R.Pretagostini, PB Berloco,

G.Novelli. Adacolumn granulocyte-aphaeresis for alcoholic hepatitis. Preliminary

study. Abstract of 23rd Conference of the Asian Pacific Association for the Study of

the Liver. Hepatology International Journal, June 2013, Volume 7, Issue 1

Supplement, pp 1-754

2013 G.Novelli, V.Morabito, G.Ferretti , F.Pugliese , M.Rossi, PB.Berloco. Soluble CD14

subtype as novel biomarker of bacterial infection in liver transplant recipients.

Abstract of 23rd Conference of the Asian Pacific Association for the Study of the

Liver. Hepatology International Journal, June 2013, Volume 7, Issue 1 Supplement, pp

1-754

2013

2013

2014

2014

V.Morabito, D.Adebayo, G.Pieri, Tu Vinh Luong, AP Dhillon, R.P.Mookerjee,

R.Jalan. Hepatocyte apoptosis is an important mechanism of cell-death in acute on

chronic liver failure. Journal of Hepatology 2013, 59, S101-S103

V.Morabito, M.Rossi, Q. Lai, F.Pugliese, P.B.Berloco, G. Novelli. Predictive Criteria

In Fulminat Hepatitis After MARS. Transplant International, Vol.26, pag.291

V.Morabito, S.Novelli, F.Bini, F.Marinozzi, G.Novelli. Artificial Liver MARS

Application In ACLF Patients: A New Concept. Abstract of 60th Annual Conference

ASAIO, 18-21 June,2013, Washington, US. ASAIO Journal, March/April 2014 -

Volume 60 - Issue 2.

V.Morabito, S.Novelli, L.Poli, PB Berloco, G.Novelli. Liver MARS application.

Abstract of 25th Conference of the Asian Pacific Association for the Study of the

Liver. Hepatology International Journal, March 2013, Volume 8, Issue 2- 1

Supplement, pp 1-754

Pubblicazioni Indexate

2006 Novelli G, Rossi M, Poli L, Pretagostini R, Iappelli M, Morabito V, Lai Q, Novelli L,

Mennini G, Ginanni Corradini S and Berloco PB. Intractable Pruritus in Patients With

Hepatitis C Virus. Transplantation Proceedings, 38, 1089–1091 (2006).

2007 Novelli G, Rossi M, Pugliese F, Poli I, Ruberto E, Martelli S, Nudo F, Morabito V,

Mennini G, Berloco PB. Molecular adsorbents recirculating system treatment in acute-

on-chronic hepatitis patients on the transplant waiting list improves model for end-

stage liver disease scores. Transplant Proc. 2007 Jul-Aug;39(6):1864-7.

2007 Novelli G, Rossi M, Poli L, Morabito V, Ferretti S, Bussotti A, Nudo F, Mennini G,

Antonellis F, Berloco PB. Is legalizing the organ market possible? Transplant Proc.

2007 Jul-Aug;39(6):1743-5

2007 Novelli G, Rossi M, Pugliese F, Poli I, Ruberto E, Martelli S, Nudo F, Morabito V,

Mennini G, Berloco PB. Molecular adsorbents recirculating system treatment in acute-

on-chronic hepatitis patients on the transplant waiting list improves model for end-

stage liver disease scores. Transplant Proc. 2007 Jul-Aug;39(6):1864-7.

2007 Pugliese F, Ruberto F, Summonti D, Perrella S, Cappannoli A, Tosi A, D'alio A,

Bruno K, Martelli S, Celli P, Morabito V, Rossi M, Berloco PB, Pietropaoli P.

Activated recombinant factor VII in orthotopic liver transplantation. Transplant Proc.

Curriculum Vitae - Dr. Vincenzo E. Morabito 2014 Il sottoscritto, ai sensi degli artt. 46 e 47 del D.P.R. 445/2000, consapevole delle conseguenze derivanti da dichiarazioni mendaci ai

sensi dell’art. 76 del D.P.R. 445/2000, dichiara:

9

2007 Jul-Aug;39(6):1883-5.

2007 Pugliese F, Ruberto F, Cappannoli A, Perrella SM, Bruno K, Martelli S, Marcellino V,

D'Alio A, Diso D, Rossi M, Corradini SG, Morabito V, Rolla M, Ferretti G, Venuta

F, Berloco PB, Coloni GF, Pietropaoli P. Incidence of fungal infections in a solid

organ recipients dedicated intensive care unit. Transplant Proc. 2007 Jul-

Aug;39(6):2005-7.

2007 Lai Q, Merli M, Ginanni Corradini S, Mennini G, Gentili F, Molinaro A, Morabito V,

Ferretti G, Pugliese F, Novelli G, Berloco PB, and Rossi M. Predictive Factors of

Recurrence of Hepatocellular Carcinoma After Liver Transplantation: A Multivariate

Analysis. Transplantation Proceedings, 41, 1306–1309 (2009).

2007 Pugliese F, Ruberto F, Perrella SM, Cappannoli A, Bruno K, Martelli S, Celli P,

Summonti D, D'Alio A, Tosi A, Novelli G, Morabito V, Poli L, Rossi M, Berloco PB,

Pietropaoli P. Modifications of intracranial pressure after molecular adsorbent

recirculating system treatment in patients with acute liver failure: case reports.

Transplant Proc. 2007 Jul-Aug;39(6):2042-4.

2008 Novelli G, Rossi M, Poli L, Morabito V, Bussotti A, Pugliese F, Ruberto F, Novelli S,

Mennini G, Berloco PB. Primary nonfunction: timing retransplantation versus

hemodynamic parameters and kidney function. Transplant Proc. 2008 Jul-

Aug;40(6):1854-7.

2008 Novelli G, Rossi M, Morabito V, Pugliese F, Ruberto F, Perrella SM, Novelli S,

Spoletini G, Ferretti G, Mennini G, Berloco PB. Pediatric acute liver failure with

molecular adsorbent recirculating system treatment. Transplant Proc. 2008 Jul-

Aug;40(6):1921-4.

2008 Pugliese F, Novelli G, Poli L, Levi Sandri GB, Di Folco G, Ferretti S, Morabito V,

Ruberto F, Berloco PB. Hemodynamic improvement as an additional parameter to

evaluate the safety and tolerability of the molecular adsorbent recirculating system in

liver failure patients. Transplant Proc. 2008 Jul-Aug;40(6):1925-8.

2009

2009

Lai Q, Merli M, Ginanni Corradini S, Mennini G, Gentili F, Molinaro A, Morabito V,

Ferretti G, Pugliese F, Novelli G, Berloco PB, and Rossi M. Predictive Factors of

Recurrence of Hepatocellular Carcinoma After Liver Transplantation: A Multivariate

Analysis. Transplantation Proceedings, 41, 1306–1309 (2009).

Novelli G, Rossi M, Ferretti G, Pugliese F, Ruberto F, Lai Q, Novelli S, Piemonte V,

Turchetti L, Morabito V, Annesini MC, Berloco PB. Predictive criteria for the

outcome of patients with acute liver failure treated with the albumin dialysis molecular

adsorbent recirculating system. Ther Apher Dial, 13, 404–412 (2009).

2009 Novelli G, Annesini MC, Morabito V, Cinti P, Pugliese F, Novelli S, Piemonte V,

Turchetti L, Rossi M, Berloco PB. Cytokine level modifications: molecular adsorbent

recirculating system versus standard medical therapy. Transplant Proc. 2009

May;41(4):1243-8

2009 Novelli G, Rossi M, Ferretti G, Poli L, Pretagostini R, Ruberto F, Morabito V, Cinti

P, Nudo F, Mennini G, Berloco PB. Adacolumn treatment in kidney transplant patients

with hepatitis C virus. Transplant Proc. 2009 May;41(4):1195-2000

2009 Novelli G, Rossi M, Ferretti G, Pugliese F, Travaglia D, Guidi S, Novelli S, Lai Q,

Morabito V, and Berloco PB. Predictive parameters after Molecular Absorbent

Recirculating System treatment integrated with Model for End Stage Liver Disease

model in patients with acute-on-chronic liver failure. Transplantation Proceedings, 42,

1182–1187 (2010).

Curriculum Vitae - Dr. Vincenzo E. Morabito 2014 Il sottoscritto, ai sensi degli artt. 46 e 47 del D.P.R. 445/2000, consapevole delle conseguenze derivanti da dichiarazioni mendaci ai

sensi dell’art. 76 del D.P.R. 445/2000, dichiara:

10

2012 V.Morabito, G.Ferretti, F.Pugliese, S.Novelli, M.Rossi, PB. Berloco, G. Novelli.

Molecular Adsorbent Recirculating System Therapy In A Rare Case Of Fulminant

Hepatitis. Journal of Biomedical Science and Engineering. Vol. 5, N.5, PP.270-

275,2012

2012 G.B. Levi Sandri, Q. Lai, V. Morabito, M. Garofalo, N. Guglielmo, F. Melandro, M.

2010 Novelli G, Ferretti G, Poli L, Pretagostini R, Ruberto F, Perrella SM, Levi Sandri GB,

Morabito V, Berloco PB. Clinical results of treatment of postsurgical endotoxin-

mediated sepsis with polymyxin-B direct hemoperfusion. Transplant Proc. 2010

May;42(4):1021-4.

2010 Lai Q, Molinaro A, Mennini G, Nudo F, Morabito V, Ginanni Corradini S, Novelli G,

Berloco PB, and Rossi M. Preoperative donor scores and postoperative early measures

of graft function: relevance to the outcome of liver transplantation. Transplantation

Proceedings, 42, 1209–1211 (2010).

2010 Novelli G, Ferretti G, Ruberto F, Morabito V, Pugliese F. Early management of

endotoxemia using the endotoxin activity assay and polymyxin B-based

hemoperfusion. Contrib Nephrol. 2010;167:91-101.

2010 C. Stefanutti, G. Novelli, V. Morabito, S. Di Giacomo, G. Labbadia. Liver

Dysfunction Supportive Therapies –From Therapeutic Plasmapheresis to Molecular

Adsorbent Recirculating System. Transplantationsmedizin 2010, 22. Jahrg., S. 325

2011 Novelli G, Morabito V, Pugliese F, Ferretti G, Novelli S, Ianni S, Lai Q, Rossi M and

Berloco PB. Management of sepsis during MARS treatment in acute on chronic liver

failure. Transplantation Proceedings, 43, 1085–1090 (2011).

2012 Levi Sandri GB, Lai Q, Melandro F, Guglielmo N, Garofalo M, Morabito V, Rossi

M, Berloco PB. Hepatic resection for giant haemangioma in a patient with a

contemporaneous adult polycystic liver disease. Clin Ter, (2012).

2012 Novelli G, Ferretti G, Morabito V,Cinti P, Poli L, Pretagostini R, Berloco B. P.

Trattamento con Adacolumn leucocitaferesi per la rimozione del Virus C nei pazienti

in lista per trapianto di rene. G Ital Nefrol. 2012 Jan-Feb;29 Suppl 54:S109-13.

2012

Lai Q, Nudo F, Mennini G, Spoletini G, Morabito V, Levi Sandri GB, Melandro F,

Guglielmo N, Berloco PB, Rossi M. Expanded criteria for hepatocellular carcinoma

after liver transplantation: a 20-year evolution. Journal of Hepato-gastroenterology,

(2012).

2012 G.Novelli; V.Morabito; Q.Lai; G.B Levi Sandri; F.Melandro; F.Pugliese;

S.Novelli;M.Rossi; PB Berloco. Glasgow Coma Score And Tumor Necrosis Factor

Alpha As Predictive Criteria For Initial Poor Graft Function. Transplant Proc. 2012

Sep;44(7):1820-5

2012 Novelli; V.Morabito; G.Ferretti; L.Poli; S.Novelli; F.Ruberto; F.Pugliese; G.

Mennini; M.Rossi; PB Berloco. Safety of polymyxin-B- based hemoperfusion in

kidney and liver transplant recipients. Transplant Proc. 2012 Sep;44(7):1966-72

2012 G.Novelli, M.Rossi, V.Morabito, G.Ferretti , R.Pretagostini, F.Ruberto, F.Pugliese,

N.Guglielmo, P.B. Berloco. Management Of Virus C Infection In Liver Transplant

With Adacolumn Apheresis. Transplant Proc. 2012 Sep;44(7):1837-42

2012

F.Marinozzi;S.Novelli;V.Morabito;P.B.Berloco;A.Corsi,A.Carpino,P.Bianco;E.Gaudi

o;M.Rossi;G.Novelli. Preliminary study of early hystomorphometric changes in

hepatic steatosis. Transplant Proc. 2012 Sep;44(7):1837-42

Curriculum Vitae - Dr. Vincenzo E. Morabito 2014 Il sottoscritto, ai sensi degli artt. 46 e 47 del D.P.R. 445/2000, consapevole delle conseguenze derivanti da dichiarazioni mendaci ai

sensi dell’art. 76 del D.P.R. 445/2000, dichiara:

11

Di Laudo, G. Montalto, P. Lucatelli, P.B. Berloco. Later diagnosed with a

neuroendocrine tumor, case report of a 60-year-old. Clin Ter 2012; 163 (5):e325-326

2013 V.Morabito, G.Novelli, R.Jalan. Use of renal replacement therapy and bioartificial

support for renal failure in cirrhosis. Clinical Liver Disease, 2013, 2 (3), 116-119

2013 Danielle Adebayo, Vincenzo Morabito, Rajiv Jalan, Acute-On-Chronic Liver Failure:

Applying The Piro Concept. EMJ Hepatol. 2013;1:38-43.

2013

2013

2013

2014

2014

2014

F Melandro, Q Lai, N Guglielmo, M Di Laudo, V Morabito, R Pretagostini, PB

Berloco, M Rossi. A case of portal vein arterialization after a liver transplant.

Experimental and Clinical Transplantation :[2013, 11(3):287-289]

Novelli G, Morabito V, Ferretti G, Pugliese F, Ruberto F, Venuta F, Poli L, Rossi

M, Berloco PB. Pathfast presepsin assay for early diagnosis of bacterial infections in

surgical patients: preliminary study. Transplant Proc. 2013 Sep;45(7):2750-3

Q Lai, F Nudo, G Mennini, G Spoletini, V Morabito, Levi GB Sandri, F Melandro, N

Guglielmo, PB Berloco, M Rossi. Expanded Criteria for Hepatocellular Carcinoma

after Liver Transplantation: A 20-Year Evolution. Hepato-Gastroenterology,Vol. 60,N

120, 2039-2041

V.Morabito, D.Adebayo. Fulminant Hepatitis: diagnosis, causes and management.

Health, April, Vol.6.

D.Adebayo, V.Morabito, A.Davenport, R.Jalan. "Renal dysfunction of cirrhosis Is

Not Just A Vasomotor Nephropathy". Kidney International Journal, Accepted in Press

V.Morabito, N.Guglielmo, F.Melandro, L.Poli, G.Mazzesi, F.Alesini, S.Bosco

P.B.Berloco. Adult Wilms Tumor: Case Report. International Journal of Urology,

accepted, in press.

CAPITOLI LIBRI

2009 Venuta F, Rossi M. Trapianti di Organi e Tessuti. Chapter 24th

: Supporti

extracorporei nelle patologie epatiche. G.Novelli, L.Poli, V.Morabito,R.Pretagostini.

Società Editrice Universo 2009.

2011 Kidney Transplantation / Book 2. Chapter: Donor Quality Scoring Systems and Early

Renal Function Measurements in Kidney Transplantation. Lai Q, Nudo F, Morabito

V, Levi Sandri GB, Melandro F, Parlati L, Guglielmo N, Di Laudo M, Garofalo M,

Poli L, Pretagostini R, Berloco PB. INTECH Open Access Publisher 2011.

2013 Annesini MC, Marrelli G, Piemonte V, Turchetti L. Artificial Organs Engineering.

Chapter 8th

. Artificial liver. V.Morabito; G. Novelli. Springer Open Access. Ahead

of publication.

2013 Cirrhosis: A practical guide to diagnosis and management. D.Adebayo,

V.Morabito, R.Jalan. Acute on Chronic Liver failure. Wiley Blackwell. Ahead of

publication.

2013 Therapy in Liver Disease. X International Meeting, September, Barcelona Section 1.

Acute On Chronic Liver Failure: Definition, Diagnosis And Prognosis.

Vincenzo Morabito, Danielle Adebayo and Rajiv Jalan.

Curriculum Vitae - Dr. Vincenzo E. Morabito 2014 Il sottoscritto, ai sensi degli artt. 46 e 47 del D.P.R. 445/2000, consapevole delle conseguenze derivanti da dichiarazioni mendaci ai

sensi dell’art. 76 del D.P.R. 445/2000, dichiara:

12

COMUNICAZIONI A CONGRESSI NAZIONALI ED INTERNAZIONALI

2006 SOCIETA’ ITALIANA TRAPIANTI D’ORGANO. XXXI Congresso Nazionale.

Dicembre 2006. Padova, Italia. Miglioramento Del Meld Nei Pazienti Con Aochf

Dopo Trattamento Mars. Poster Communication.

2006 AMERICAN SOCIETY FOR ARTIFICIAL INTERNAL ORGANS. 52rd Annual

Conference. Chicago,USA.

A) Intractable pruritus in patiens with HCV. Personal experience. Poster

Communication. B) MARS treatment in AOCHF patients on TX waiting list improves MELD score.

Poster Communication.

2007 ANNUAL DIALYSIS CONFERNENCE. Denver, Colorado, USA.

A) MARS Treatment In Acute Liver Failure Patients With Hepatorenal Syndrome.

Poster Communication. B) MARS Treatments As Predictive Criteria For Liver Transplantation In Liver

Failure. Poster Communication.

2007 AMERICAN SOCIETY FOR ARTIFICIAL INTERNAL ORGANS. 53rd Annual

Conference. Chicago, USA.

A) Follow Up Of AoCHF Patients At Six Months After MARS Treatment. Poster

Communication.

B) MARS Treatment In Acute Liver Failure Patients With Hepatorenal Syndrome.

Poster Communication.

2007 INTERNATIONAL SOCIETY OF NEPHROLOGY WORLD CONGRESS. Rio de

Janeiro, Brazil

A) Is Legalizing The Organ Market Possible? Poster Communication

B) Safety Of Mars Treatment : Personal Experience Poster Communication

2007 SOCIETA’ ITALIANA TRAPIANTI D’ORGANO. XXXII Congresso Nazionale.

Modena, Italia

L’insufficienza epatica pediatrica: ruolo del MARS. Oral Communication

2008 37th CRITICAL CARE CONGRESS.Hawaii.

A) Acute Liver Failure: Hemodynamic Parameters Improvement Through MARS.

Oral Communication

B) Pediatric Acute Liver Failure In Treatment With Mars. Poster Communication

2008 5TH INTERNATIONAL SYMPOSIUM OF THE DEFINITION OF DEATH

NETWORK. Varadero, Cuba

Monitoring Hemodynamic Parameters During Molecular Adsorbent Recycling System

Sessions In Pantients With Primary Non Function. Oral Communication

2008 4th INTERNATIONAL LIVER CONGRESS. June 2008. Hong Kong.

Safety and efficacy of Molecular Adsorption Recirculating System in Acute Liver

Failure. Oral Communication

2008 JOINT INTERNATIONAL CONGRESS OF ILTS, ELITA and LICAGE. Paris,

France

Primary Non Function: Timing Re-Transplant Versus Hemodynamic Parameters And

Kidney Function. Poster Communication

2008 XXII INTERNATIONAL CONGRESS OF THE TRANSPLANTATION SOCIETY.

SYDNEY 2008.

A New Score Of Survival In Patients With Acute Liver Failure: Role Of Mars. Poster

Communication

Curriculum Vitae - Dr. Vincenzo E. Morabito 2014 Il sottoscritto, ai sensi degli artt. 46 e 47 del D.P.R. 445/2000, consapevole delle conseguenze derivanti da dichiarazioni mendaci ai

sensi dell’art. 76 del D.P.R. 445/2000, dichiara:

13

2008 10TH INTERNATIONAL SYMPOSIUMON ALBUMIN DIALYSIS IN LIVER

DISEASE SEPTEMBER 2008 ROSTOCK. GERMANY. Predictive Criteria For

The Outcome Of Patients With Alf Treated With Albumin Dialysis Mars. Oral

Communication

2008 XXXIV European Society of Artificial Organ (ESAO) CONGRESS. Krems, Austria

A)MARS Versus Standard Medical Therapy: Effects On Cytokines Levels. Poster

Communication

2008 SECOND DITAN INTERNATIONAL SYMPOSIUM ON INFECTIOUS DISEASES.

Bejing, China Treatment With Adacolumn In Patients With Hepatitis C Related Who

Have Undergone Kidney Transplantation: Preliminary Study. Oral communication

2008 SOCIETA’ ITALIANA TRAPIANTI D’ORGANO. XXXII Congresso Nazionale.

Sorrento, Italia.

A)Modificazioni Della Concentrazione Delle Citochine. Molecular Adsorbent

Recirculating System Versus Terapia Medica Standard. Oral Communication

B)Adacolumn Leucocitaferesi Nel Trattamento Dell’ HCV. Studio Preliminare. Oral

communication

2009 INTERNATIONAL LIVER TRANSPLANT SOCIETY CONGRESS. New York,

USA

A)Preliminary study: Adacolumn Apheresis treatment in kidney transplant patients

with Hepatitis C virus. Poster Communication

B)Predictive Criteria For Patients Outcome With Acute Liver Failure: Albumin

Dialysis Mars. Oral communication

2009

SOCIETA’ ITALIANA TRAPIANTI D’ORGANO.

XXXIII Congresso Nazionale. Milano, Italia.

A) Criteri predittivi per l’outcome in pazienti con insufficienza epatica acuta:

molecular adsorbent recirculating system. Oral Communication

B) Valutazione Precoce Dell’ Endotossinemia In Pazienti Affetti Da Sepsi Nel Periodo

Post Operatorio Mediante Lo Spectral's Endotoxin Activity Assay. Oral

Communication

2010 XX ASIAN PACIFIC ASSOCIATION OF STUDY OF THE LIVER (APASL)

CONGRESS. Bejing, China

A) Early management of endotoxemia using the Endotoxin Activity Assay and

Polymyxin-B based hemoperfusion. Poster Communication

B) Predictive criteria for the outcome of patients with Fulminant Hepatitis after

Molecular Adsorbent Recirculating System treatment. Oral Communication

2010 XXIII TRANSPLANT SOCIETY CONGRESS. VANCOUVER, CANADA.

Endotoxin Activity Assay and Polimyxyn-B in early management of endotoxemia.

Poster Communication

2010 XXIII TRANSPLANT SOCIETY CONGRESS. VANCOUVER, CANADA.

Endotoxin Activity Assay and Polimyxyn-B in early management of endotoxemia.

Poster Communication

2010 XXXV EUROPEAN SOCIETY OF ARTIFICIAL ORGANS CONGRESS. SKOPJE ,

MACEDONIA

a) Endotoxemia activity in post surgical patients. Role of Endotoxin Activity Assay

and Polimyxyn-B in early management. Oral Communication

b) Mathematical Model Application for predictive criteria in fulminant hepatitis. Oral

Communication

c) Correlation between the severity of liver disease and image analysis of histological

findings. Preliminary study. Poster Communication

Curriculum Vitae - Dr. Vincenzo E. Morabito 2014 Il sottoscritto, ai sensi degli artt. 46 e 47 del D.P.R. 445/2000, consapevole delle conseguenze derivanti da dichiarazioni mendaci ai

sensi dell’art. 76 del D.P.R. 445/2000, dichiara:

14

2010 SOCIETA’ ITALIANA TRAPIANTI D’ORGANO. XXXIV Congresso Nazionale.

Ancona Italia

a) Management della SIRS in pazienti con cirrosi scompensata. Ruolo della dialisi

d’albumina MARS e del Polymyxin-B based hemoperfusion. Oral communication

b) Predictive criteria for the outcome of patients with Fulminant Hepatitis after

Molecular Adsorbent Recirculating System treatment. Oral communication

c) Test EAA per la valutazione dell’attività endotossinica e Polimixin B based

Hemoperfusion. Oral communication

2011 MONOTHEMATIC CONFERENCE: EVALUATION OF DISEASE SEVERITY

AND PROGNOSIS IN CHRONIC LIVER DISEASE. (EASL). NICE, FRANCE.

Endotoxin Activity Assay for early diagnosis of SIRS in AoCLF patients. Poster

Communication

2011 AMERICAN SOCIETY OF INTERNAL ARTIFICIAL ORGANS (ASAIO) 57th

ANNUAL CONFERNCE. WASHINGTON DC, USA

a)Matematical model to improve albumin dialysis MARS. Poster Communication

b) Preliminary study of early hystomorphometric changes in hepatic steatosis. Poster

Communication

2011 XXXVII EUROPEAN SOCIETY OF ARTIFICIAL ORGANS (ESAO) CONGRESS,

Porto, Portugal

a)Test EAA for endotoxin activity in Acute on Chronic Liver Failure. Oral

communication b)Delayed Graft Function in liver transplant. Role of Molecular Adsorbent

Recirculating System. Oral communication

c)Histomorphometric analysis in the progression of hepatic steatosis. Oral

communication

2011

XXXV CONGRESSO NAZIONALE SOCIETÀ ITALIANA TRAPIANTI

D’ORGANO, Rome, Italy

a)Management dell’endotoxemia nei pazienti sottoposti a trapianto d’organo. Oral

communication b)Delayed Graft Function nel trapianto di fegato. Ruolo del Molecular Adsorbent

Recirculating System. Oral communication

c)Adacolumn leucocitaferesi nel trattamento dell’ infezione da Virus C nei pazienti

sottoposti a trapianto di fegato. Studio preliminare. Oral communication

2011 AMERICAN ASSOCIATION OF THE STUDY OF LIVER DISEASE (AASLD)

CONGRESS. SAN FRANCISCO, USA.

Experience in sepsis patients after liver transplant. Poster communication

2012 22ND CONFERENCE OF THE ASIAN PACIFIC ASSOCIATION FOR THE

STUDY OF THE LIVER(APASL), Taipei, Taiwan.

a) Artificial Liver: What do we need to know about albumin dialysis MARS?

PosterCommunication b) Preliminary study for new therapy of Virus C infection in liver transplant

Postercommunication c) Endotoxemia management in liver transplant patients. Poster communication

d) Predictive criteria to assess initial poor graft function in liver transplant . Poster

2012 AMERICAN TRANSPLANT SOCIETY, ANNUAL CONGRESS, 2-6 JUNE,

BOSTON, US.:

a)Initial Poor Graft Failure after liver transplant. Role of albumin dialysis MARS.

Poster communication b)Endotoxin acitivity management in liver transplant recipients. Oral communication

Curriculum Vitae - Dr. Vincenzo E. Morabito 2014 Il sottoscritto, ai sensi degli artt. 46 e 47 del D.P.R. 445/2000, consapevole delle conseguenze derivanti da dichiarazioni mendaci ai

sensi dell’art. 76 del D.P.R. 445/2000, dichiara:

15

2012 TRANSPLANT SOCIETY WORLD CONGRESS, 15-19 JULY, BERLIN,

GERMANY:

a) Albumin dialysis MARS: A Engineering Analysis. Poster communication

b) New predictive criteria for outcome after Albumin dialysis MARS in liver

transplant recipients with initial poor graft function. Poster communication

c) Adacolumn apheresis for treatment of Virus C infection in liver transplant

recipients. Poster communication

d) PATHFAST Presepsin assay for early diagnosis of bacterial infections in surgical

patients. Preliminary study. Poster communication

2013

2013

2013

2013

2014

2014

2014

2014

INTERNATIONAL LIVER CONGRESS of EASL, AMSTERDAM,

NETHERLANDS, APRIL 24-28:

a)Predictive Criteria For The Outcome Of Patients With Fulminat Hepatitis Treated

With Mars. Update.

b) Diagnostic Value Of Presepsin In Cirrhotic Patients. Oral communication

59TH ANNUAL CONFERENCE | ASAIO AMERICAN SOCIETY OF ARTIFICIAL

INTERNAL ORGANS, CHICAGO 2013, 12-15 JUNE

a) Polymyxin B-Hemoperfusion and Endotoxin Actitivity Assay in kidney transplants

b) Detoxification efficiency of Molecular Adsorbent Recirculating System. Poster

communication

14TH INTERNATIONAL SYMPOSIUM ON ALBUMIN DIALYSIS, ROSTOCK,

GERMANY, 27-29 SEPTEMBER

a) Panel Discussion - How can we serve the patient best in the need of Liver Support

in the MELD allocation era? Chairs: Angeli P, Crusius A, Gutmann T, Jalan R,

Mitzner S, Morabito V, Trowe E

b) Evolution of MARS application. Oral communication

XXXVII CONGRESSO NAZIONALE SOCIETÀ ITALIANA TRAPIANTI

D’ORGANO, BARI, ITALY 24-26 OTTOBRE

a) Presepsina come biomarcatore precoce delle infezioni batteriche nei pazienti con

cirrosi epatica. Oral communication

b) Criteri Predittivi nei pazienti affetti da epatite fulminante trattati con il fegato

artificial MARS.Update Oral communication

c) Terapia dell’epatite alcolica mediante l’uso dell’Aacolumn Leucocitaferesi.Studio

preliminare. Oral communication

d) Analisi istomorfometrica del rene da donatore cadavere per l’idoneità al trapianto.

Oral communication

24ND CONFERENCE OF THE ASIAN PACIFIC ASSOCIATION FOR THE

STUDY OF THE LIVER(APASL), BRISBANE 12 – 15 MARCH 2014.

Liver MARS: what’s new? Poster Communication.

EASL MONOTHEMATIC CONFERENCE: PRIMARY BILIARY CIRRHOSIS, 23-

24 MAY, MILAN,ITALY.

Treatment Of Intractable Pruritus With Artificial Liver Mars.Poster Communication.

60TH

ASAIO ANNUAL CONFERENCE WASHINGTON, D.C. 18-21 JUNE. Artificial Liver MARS Application In ACLF Patients: A New Concept. Oral

communication.

2014 JOINT INTERNATIONAL CONGRESS OF ILTS, ELITA & LICAGE,

JUNE 4 – 7, 2014, LONDON, UNITED KINGDOM.

Prognostic Criteria After Artificial Liver Mars In Fulminant Hepatitis. Poster

Communication

Curriculum Vitae - Dr. Vincenzo E. Morabito 2014 Il sottoscritto, ai sensi degli artt. 46 e 47 del D.P.R. 445/2000, consapevole delle conseguenze derivanti da dichiarazioni mendaci ai

sensi dell’art. 76 del D.P.R. 445/2000, dichiara:

16

AFFILIAZIONI

Dal 2006 Membro della SITO (Società Italiana dei Trapianti d’Organo)

Dal 2010 Membro dell’ EASL (European Association for the Study of the Liver)

Dal 2011 Membro dell’ ESOT (European Society for Organ Transplantation)

Dal 2011 Membro dell’ ASAIO (American Society of Artificial Internal Organs)

Roma 28.04.2014

Dr. Vincenzo Emiliano Morabito